Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

125.10
Delayed Data
As of Jul 27
 -6.30 / -4.79%
Today’s Change
110.90
Today|||52-Week Range
169.89
-12.78%
Year-to-Date

Today’s Trading

Previous close131.40
Today’s open134.01
Day’s range123.05 - 134.33
Volume1,430,489
Average volume (3 months)579,965
Market cap$5.9B
Dividend yield--
Data as of 07/27/2017

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-5.76%
Earnings growth (next 5 years)-6.70%
Revenue growth (last year)+9.08%
P/E ratio8.7
Price/Sales4.20
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-0.64-3.60%
GRFSGrifols SA-0.08-0.40%
IONSIonis Pharmaceutical...-2.25-4.14%
PTHNPatheon NV+0.03+0.09%
Data as of 07/27/2017

Financials

Last reporting dateJuly 27, 2017
EPS forecast (this quarter)$3.54
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts